Dogwood Therapeutics, Inc. beat EPS estimates 100% of the time across 1 reported quarters (1 beats, 0 misses), averaging +31.8% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | not reported | $-0.34 | not reported | not reported | |
| Q1 FY26 | $-0.22 | $-0.15 | +31.8% | Beat | |
| Q4 FY25 | not reported | $-0.26 | not reported | not reported |
Back to DWTX overview · DWTX holders · DWTX KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.